Gastric mucosal protection: From the periphery to the central nervous system

Journal of Physiology and Pharmacology

Volumn 66, Issue 3, 2015, Pages 319-329

  Gyires, K ^a   Toth, V E ^a   Zadori, Z S ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

A2 adrenoceptors; Central nervous system; Centrally induced gastroprotection; Gastric mucosal protection; Mediators; Neuropeptides; Opioid receptors; Peripherally induced gastroprotection

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 4 AMINOBUTYRIC ACID; ACETYLSALICYLIC ACID; ADRENOMEDULLIN; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; APADENOSON; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR CXCR4; DELTA OPIATE RECEPTOR; INDOMETACIN; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NALTRINDOLE; NEUROKININ; NOCICEPTIN; NORADRENALIN; OPIATE PEPTIDE; PROSTAGLANDIN; PROTEINASE ACTIVATED RECEPTOR; PROTIRELIN RECEPTOR; SOMATOSTATIN; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; YOHIMBINE; EXCITATORY AMINO ACID; NEUROPEPTIDE; NITRIC OXIDE; OPIATE RECEPTOR;

ARTICLE; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; GASTROINTESTINAL TRACT FUNCTION; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; ID50; IMMUNE RESPONSE; INFLAMMATION; LIPID PEROXIDATION; METABOLIC REGULATION; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; STOMACH LESION; STOMACH MUCOSA; STOMACH MUCUS; STOMACH PROTECTION; SYNAPTIC TRANSMISSION; VAGUS NERVE DORSAL NUCLEUS; ANIMAL; GASTRIC MUCOSA; METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM; EXCITATORY AMINO ACIDS; GASTRIC MUCOSA; HUMANS; NEUROPEPTIDES; NITRIC OXIDE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID;

EID: 84930893974     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (117)

1. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? Physiol Rev 2008; 88: 1547-1565.
2. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008; 135: 41-60.
3. Gyires K, Nemeth J, Zadori ZS. Gastric mucosal protection and central nervous system. Curr Pharm Des 2013; 19: 34-39.
4. deFoneska A, Kaunitz JD. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2010; 26: 604-610.
5. Allen A, Flemstrom G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 2005; 288: 1-19.
6. Takeuchi K. Gastric cytoprotection by prostaglandin E2 and prostacyclin: relationship to EP1 and IP receptors. J Physiol Pharmacol 2014; 65: 3-14.
7. Kotani T, Kobata A, Nakamura E, Amagase K, Takeuchi K. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach. J Pharmacol Exp Ther 2006; 316: 547-555.
8. Li DS, Raybould HE, Quintero E, Guth PH. Calcitonin generelated peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology 1992; 102: 1124-1128.
9. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 823-839.
10. Gyires K. Neuropeptides and gastric mucosal homeostasis. Curr Top Med Chem 2004; 4: 63-73.
11. Holzer P. Role of visceral afferent neurons in mucosal inflammation and defense. Curr Opin Pharmacol 2007; 7: 563-569.
12. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats. Dig Dis Sci 1994; 39: 617-625.
13. Nassar NN, Schaalan MF, Zaki HF, Abdallah DM. Octreotide ameliorates gastric lesions in chronically mild stressed rats. World J Gastroenterol 2011; 17: 1135-1142.
14. Szabo S, Nagy L, Plebani M. Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection. Clin Chim Acta 1992; 206: 95-105.
15. Ali AT. The role of nitric oxide and sulphydryls in gastric mucosal protection induced by sodium cromoglycate in rats. J Pharm Pharmacol 1995; 47: 739-743.
16. Wallace JL. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid Redox Signal 2010; 12: 1125-1133.
17. Fiorucci S, Antonelli E, Distrutti E, et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005; 129: 1210-1224.
18. Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br J Pharmacol 2010; 159: 1236-1246.
19. Wallace JL. Hydrogen sulfide: a rescue molecule for mucosal defence and repair. Dig Dis Sci 2012; 57: 1432-1434.
20. Al Jiboury H, Kaunitz JD. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2012; 28: 594-601.
21. Kwiecien S, Jasnos K, Magierowski M, et al. Lipid peroxidation, reactive oxygen species and antioxidative factors in the pathogenesis of gastric mucosal lesions and mechanism of protection against oxidative stress - induced gastric injury. J Physiol Pharmacol 2014; 65: 613-622.
22. Bindu S, Mazumder S, Dey S, et al. Nonsteroidal antiinflammatory drug induces proinflammatory damage in gastric mucosa through NF-kappaB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against nonsteroidal anti-inflammatory drug. Free Radic Biol Med 2013; 65: 456-467.
23. Davies GR, Simmonds NJ, Stevens TR, Grandison A, Blake DR, Rampton DS. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467-1472.
24. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554.
25. Llesuy SF, Tomaro ML. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1994; 1223: 9-14.
26. Guo JS, Cho CH, Wang WP, Shen XZ, Cheng CL, Koo MW. Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats. World J Gastroenterol 2003; 9: 1767-1771.
27. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
28. Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Domschke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech 2001; 53: 396-408.
29. Park SH, Hong H, Han YM, et al. Nonsteroidal antiinflammatory drugs (NSAID) sparing effects of glucosamine hydrochloride through N-glycosylation inhibition; strategy to rescue stomach from NSAID damage. J Physiol Pharmacol 2013; 64: 157-165.
30. Pradeepkumar Singh L, Vivek Sharma A, Swarnakar S. Upregulation of collagenase-1 and -3 in indomethacininduced gastric ulcer in diabetic rats: role of melatonin. J Pineal Res 2011; 51: 61-74.
31. Kim SJ, Park YS, Paik HD, Chang HI. Effect of anthocyanins on expression of matrix metalloproteinase-2 in naproxen-induced gastric ulcers. Br J Nutr 2011; 106: 1792-1801.
32. Ganguly K, Swarnakar S. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res 2009; 47: 43-55.
33. Li SL, Zhao JR, Ren XY, Xie JP, Ma QZ, Rong QH. Increased expression of matrix metalloproteinase-9 associated with gastric ulcer recurrence. World J Gastroenterol 2013; 19: 4590-4595.
34. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 2005; 62: 2932-2938.
35. Hoffmann W. Trefoil factor family (TFF) peptides: regulators of mucosal regeneration and repair, and more. Peptides 2004; 25: 727-730.
36. Konturek PC, Brzozowski T, Konturek SJ, et al. Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats. Regul Pept 1997; 68: 71-79.
37. Farrell JJ, Taupin D, Koh TJ, et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002; 109: 193-204.
38. Xue L, Aihara E, Wang TC, Montrose MH. Trefoil factor 2 requires Na/H exchanger 2 activity to enhance mouse gastric epithelial repair. J Biol Chem 2011; 286: 38375-38382.
39. Dubeykovskaya Z, Dubeykovskiy A, Solal-Cohen J, Wang TC. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J Biol Chem 2009; 284: 3650-3662.
40. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293-1299.
41. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: 222-229.
42. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defense. FASEB J 1996; 10: 731-740.
43. Bodger K, Wyatt JI, Heatley RV. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997; 40: 739-744.
44. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824.
45. Ward SM, Bayguinov J, Won KJ, Grundy D, Berthoud HR. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 2003; 465: 121-135.
46. Zhao H, Simasko SM. Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons. Endocrinology 2010; 151: 5237-5246.
47. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004; 38: 377-384.
48. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
49. Holzer P. Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 2011; 131: 142-170.
50. Szolcsanyi J, Bartho L. Capsaicin-sensitive afferents and their role in gastroprotection: an update. J Physiol (Paris) 2001; 95: 181-188.
51. Holzer P, Lippe IT. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience 1988; 27: 981-987.
52. Mozsik G, Szolcsanyi J, Domotor A. Capsaicin research as a new tool to approach of the human gastrointestinal physiology, pathology and pharmacology. Inflammopharmacology 2007; 15: 232-245.
53. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 2007; 19: 3-10.
54. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.
55. Smith MF, Jr., Mitchell A, Li G, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278: 32552-32560.
56. Nadatani Y, Watanabe T, Tanigawa T, et al. High-mobility group Box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. PLoS One 2013; 8: e80130.
57. Lagunes-Servin H, Torres J, Maldonado-Bernal C, et al. Toll-like receptors and cytokines are upregulated during Helicobacter pylori infection in children. Helicobacter 2013; 18: 423-432.
58. Nishikawa H, Kawai K, Nishimura S, et al. Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats. Eur J Pharmacol 2002; 447: 87-90.
59. Kawabata A, Nishikawa H, Saitoh H, et al. A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 2004; 126: 208-219.
60. Kawabata A, Kinoshita M, Nishikawa H, et al. The proteaseactivated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 2001; 107: 1443-1450.
61. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76: 5-13.
62. Odashima M, Otaka M, Jin M, et al. Selective adenosine A receptor agonist, ATL-146e, attenuates stress-induced gastric lesions in rats. J Gastroenterol Hepatol 2005; 20: 275-280.
63. Odashima M, Otaka M, Jin M, et al. Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats. World J Gastroenterol 2006; 12: 568-573.
64. Koizumi S, Odashima M, Otaka M, et al. Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats. J Gastroenterol 2009; 44: 419-425.
65. Nishimura E, Buchan AM, McIntosh CH. Autoradiographic localization of opioid receptors in the rat stomach. Neurosci Lett 1984; 50: 73-78.
66. Gyires K, Ronai AZ, Toth G, Darula Z, Furst S. Analysis of the role of delta opioid receptors in gastroprotection in the rat. Life Sci 1997; 60: 1337-1347.
67. Gyires K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur J Pharmacol 1994; 255: 33-37.
68. Gyires K, Zadori ZS, Shujaa N, Minorics R, Falkay G, Matyus P. Analysis of the role of central and peripheral alpha2-adrenoceptor subtypes in gastric mucosal defense in the rat. Neurochem Int 2007; 51: 289-296.
69. Zadori ZS, Shujaa N, Brancati SB, Hein L, Gyires K. Both alpha2B- and alpha2C-adrenoceptor subtypes are involved in the mediation of centrally induced gastroprotection in mice. Eur J Pharmacol 2011; 669: 115-120.
70. Fulop K, Zadori Z, Ronai AZ, Gyires K. Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence. Eur J Pharmacol 2005; 528: 150-157.
71. Gyires K, Ronai AZ. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat. J Pharmacol Exp Ther 2001; 297: 1010-1015.
72. Tache Y, Adelson D, Yang H. TRH/TRH-R1 receptor signaling in the brain medulla as a pathway of vagally mediated gut responses during the cephalic phase. Curr Pharm Des 2014; 20: 2725-2730.
73. Gyires K. Analysis of the Effect of Different Neuropeptides in Gastric Mucosal Defense Initiated Centrally. In: Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment, Filaretova LP, Takeuchi K (eds). Basel, Karger, 2012, vol 30, pp. 161-169.
74. Yang H, Kawakubo K, Tache Y. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways. Am J Physiol 1999; 277: G555-G562.
75. Tache Y, Yoneda M. Central action of TRH to induce vagally mediated gastric cytoprotection and ulcer formation in rats. J Clin Gastroenterol 1993; 17: 58-63.
76. Tache Y. Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents. Curr Med Chem 2012; 19: 35-42.
77. Kaneko H, Mitsuma T, Nagai H, et al. Central action of adrenomedullin to prevent ethanol-induced gastric injury through vagal pathways in rats. Am J Physiol 1998; 274: 1783-1788.
78. Gyires K, Ronai AZ, Mullner K, Furst S. Intracerebroventricular injection of clonidine releases beta-endorphin to induce mucosal protection in the rat. Neuropharmacology 2000; 39: 961-968.
79. Zadori ZS, Shujaa N, Koles L, Kiraly KP, Tekes K, Gyires K. Nocistatin and nociceptin given centrally induce opioidmediated gastric mucosal protection. Peptides 2008; 29: 2257-2265.
80. Gyires K, Ronai AZ, Zadori ZS, et al. Angiotensin IIinduced activation of central AT receptors exerts endocannabinoid-mediated gastroprotective effect in rats. Mol Cell Endocrinol 2014; 382: 971-978.
81. Browning KN, Travagli RA. Short-term receptor trafficking in the dorsal vagal complex: an overview. Auton Neurosci 2006; 126-127: 2-8.
82. Willis A, Mihalevich M, Neff RA, Mendelowitz D. Three types of postsynaptic glutamatergic receptors are activated in DMNX neurons upon stimulation of NTS. Am J Physiol 1996; 271: 1614-1619.
83. Travagli RA, Gillis RA, Rossiter CD, Vicini S. Glutamate and GABA-mediated synaptic currents in neurons of the rat dorsal motor nucleus of the vagus. Am J Physiol 1991; 260: G531-G536.
84. Davis SF, Derbenev AV, Williams KW, Glatzer NR, Smith BN. Excitatory and inhibitory local circuit input to the rat dorsal motor nucleus of the vagus originating from the nucleus tractus solitarius. Brain Res 2004; 1017: 208-217.
85. Browning KN, Travagli RA. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus. J Physiol 2003; 549: 775-785.
86. Sivarao DV, Krowicki ZK, Abrahams TP, Hornby PJ. Vagally-regulated gastric motor activity: evidence for kainate and NMDA receptor mediation. Eur J Pharmacol 1999; 368: 173-182.
87. Takeuchi K, Nishiwaki H, Okabe S. Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-adrenoceptors. Dig Dis Sci 1988; 33: 1560-1568.
88. Takeuchi K, Niida H, Matsumoto J, Ueshima K, Okabe S. Gastric motility changes in capsaicin-induced cytoprotection in the rat stomach. Jpn J Pharmacol 1991; 55: 147-155.
89. Kiraly A, Suto G, Tache Y. Role of nitric oxide in the gastric cytoprotection induced by central vagal stimulation. Eur J Pharmacol 1993; 240: 299-301.
90. Kiraly A, Suto G, Livingston EH, Guth PH, St Pierre S, Tache Y. Central vagal activation by TRH induces gastric hyperemia: role of CGRP in capsaicin-sensitive afferents in rats. Am J Physiol 1994; 267: G1041-G1049.
91. Kato K, Matsuno Y, Matsuo Y, et al. Role of mucosal prostaglandins in vagally-mediated adaptive cytoprotection in the rat. Gastroenterol Jpn 1992; 27: 1-8.
92. Mansour A, Fox CA, Burke S, et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 1994; 350: 412-438.
93. Mansour A, Fox CA, Burke S, Akil H, Watson SJ. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 1995; 8: 283-305.
94. Namiki T, Egawa M, Tominaga S, Inoue S, Takamura Y. Effects of GABA and L-glutamate on the gastric acid secretion and gastric defensive mechanisms in rat lateral hypothalamus. J Auton Nerv Syst 1993; 44: 217-223.
95. Kaneko H, Kaunitz J, Tache Y. Vagal mechanisms underlying gastric protection induced by chemical activation of raphe pallidus in rats. Am J Physiol 1998; 275: 1056-1062.
96. Lin LH, Talman WT. N-methyl-D-aspartate receptors on neurons that synthesize nitric oxide in rat nucleus tractus solitarii. Neuroscience 2000; 100: 581-588.
97. Matsuo I, Hirooka Y, Hironaga K, et al. Glutamate release via NO production evoked by NMDA in the NTS enhances hypotension and bradycardia in vivo. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1285-R1291.
98. Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 2001; 24: 211-215.
99. Tavares A, Handy DE, Bogdanova NN, Rosene DL, Gavras H. Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brain. Hypertension 1996; 27: 449-455.
100. Rosin DL, Talley EM, Lee A, et al. Distribution of alpha 2Cadrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 1996; 372: 135-165.
101. Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329-332.
102. Partosoedarso ER, Abrahams TP, Scullion RT, Moerschbaecher JM, Hornby PJ. Cannabinoid 1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J Physiol 2003; 550: 149-158.
103. Castelli MP, Piras AP, Melis T, et al. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. Neuroscience 2007; 147: 197-206.
104. Accorsi-Mendonca D, Almado CE, Dagostin AL, Machado BH, Leao RM. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors. Brain Res 2008; 1200: 1-9.
105. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain. Neuroscience 1998; 82: 827-841.
106. Diz DI, Barnes KL, Ferrario CM. Hypotensive actions of microinjections of angiotensin II into the dorsal motor nucleus of the vagus. J Hypertens Suppl 1984; 2: 53-56.
107. Neal CR, Jr., Mansour A, Reinscheid R, et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 1999; 412: 563-605.
108. Polidori C, Massi M, Guerrini R, Grandi D, Lupo D, Morini G. Peripheral mechanisms involved in gastric mucosal protection by intracerebroventricular and intraperitoneal nociceptin in rats. Endocrinology 2005; 146: 3861-3867.
109. Mazzone SB, Geraghty DP. Characterization and regulation of tachykinin receptors in the nucleus tractus solitarius. Clin Exp Pharmacol Physiol 2000; 27: 939-942.
110. Lewis MW, Travagli RA. Effects of substance P on identified neurons of the rat dorsal motor nucleus of the vagus. Am J Physiol Gastrointest Liver Physiol 2001; 281: G164-G172.
111. Dixon MK, Nathan NA, Hornby PJ. Immunocytochemical distribution of neurokinin 1 receptor in rat dorsal vagal complex. Peptides 1998; 19: 913-923.
112. Shujaa N, Zadori ZS, Ronai AZ, et al. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. J Physiol Pharmacol 2009; 60 (Suppl.7): 93-100.
113. Brancati SB, Zadori ZS, Nemeth J, Gyires K. Substance P induces gastric mucosal protection at supraspinal level via increasing the level of endomorphin-2 in rats. Brain Res Bull 2013; 91: 38-45.
114. Benyhe Z, Toth G, Wollemann M, et al. Effects of synthetic analogues of human opiorphin on rat brain opioid receptors. J Physiol Pharmacol 2014; 65: 525-530.
115. Ray A, Henke PG. TRH-enkephalin interactions in the amygdaloid complex during gastric stress ulcer formation in rats. Regul Pept 1991; 35: 11-17.
116. Nikolarakis KE, Almeida OF, Herz A. Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro). Brain Res 1986; 399: 152-155.
117. Mizoguchi H, Watanabe H, Hayashi T, et al. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2. J Pharmacol Exp Ther 2006; 317: 362-368.